Loermann, G.; Kolb, M.; Prascevic, D.; Siemert, J.; Wiegand, S.; Zebralla, V.; Pirlich, M.; Stöhr, M.; Dietz, A.; Wald, T.;
et al. High-Risk Human Papillomavirus (HR-HPV) DNA Detection in Mouthwashes for Diagnosis of HPV-Driven Oropharynx Cancer and Its Curative Therapy—A Feasibility Study. J. Clin. Med. 2022, 11, 5509.
https://doi.org/10.3390/jcm11195509
AMA Style
Loermann G, Kolb M, Prascevic D, Siemert J, Wiegand S, Zebralla V, Pirlich M, Stöhr M, Dietz A, Wald T,
et al. High-Risk Human Papillomavirus (HR-HPV) DNA Detection in Mouthwashes for Diagnosis of HPV-Driven Oropharynx Cancer and Its Curative Therapy—A Feasibility Study. Journal of Clinical Medicine. 2022; 11(19):5509.
https://doi.org/10.3390/jcm11195509
Chicago/Turabian Style
Loermann, Gera, Marlen Kolb, Dusan Prascevic, Julia Siemert, Susanne Wiegand, Veit Zebralla, Markus Pirlich, Matthäus Stöhr, Andreas Dietz, Theresa Wald,
and et al. 2022. "High-Risk Human Papillomavirus (HR-HPV) DNA Detection in Mouthwashes for Diagnosis of HPV-Driven Oropharynx Cancer and Its Curative Therapy—A Feasibility Study" Journal of Clinical Medicine 11, no. 19: 5509.
https://doi.org/10.3390/jcm11195509
APA Style
Loermann, G., Kolb, M., Prascevic, D., Siemert, J., Wiegand, S., Zebralla, V., Pirlich, M., Stöhr, M., Dietz, A., Wald, T., & Wichmann, G.
(2022). High-Risk Human Papillomavirus (HR-HPV) DNA Detection in Mouthwashes for Diagnosis of HPV-Driven Oropharynx Cancer and Its Curative Therapy—A Feasibility Study. Journal of Clinical Medicine, 11(19), 5509.
https://doi.org/10.3390/jcm11195509